ArticleFrontiers in pharmacology2016

Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.

Florian M Ottenlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.